Literature DB >> 21964743

EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.

Muslim Atiq1, Manoop S Bhutani, Mehmet Bektas, Jeffrey E Lee, Yun Gong, Eric P Tamm, Chintan P Shah, William A Ross, James Yao, Gottumukkala S Raju, Xuemei Wang, Jeffrey H Lee.   

Abstract

OBJECTIVES: Pancreatic neuroendocrine tumors (PNET) are fairly uncommon. Recent data highlight the importance of EUS in diagnosis of PNET. With this background, we decided to review our experience from a tertiary cancer center with regard to the presentation and clinical features of PNET and the diagnostic utility of EUS-FNA in this scenario.
METHODS: We identified patients who underwent EUS at our institution between January 1st 2001 and December 31st 2009 for a suspected PNET. Data on clinical features, cross-sectional imaging findings, EUS findings, and cytology results were collected.
RESULTS: A total of 81 patients were referred for EUS-FNA for a suspected PNET. Mean age was 58.1 years. There were 41 (50.6%) males. PNET was found incidentally in 38 (46.9%) patients. Computed tomography scanning identified a pancreatic mass in 72 out of 79 (91.1%) cases. Mean diameter of the largest lesion seen on EUS was 27.5 mm (range: 6.9-80 mm). The most common site (34; 42%) was the head of the pancreas. EUS-FNA correctly confirmed a PNET in 73 out of 81 cases with diagnostic accuracy of 90.1%. Seven (8.6%) out of 81 patients had functional lesions, including three gastrinomas and four insulinomas. Liver metastases were found in 31 out of 81 (38.3%) cases. Of the 31 patients with liver metastasis, the mean diameter of lesions on EUS was 33.9 mm compared with 23.5 mm in patients without liver metastasis (P = 0.005).
CONCLUSION: EUS-FNA is a reliable modality for further characterization of suspected lesions and for establishing a tissue diagnosis. The occurrence of complications of EUS-FNA in this setting is low. Non-functional PNET are more frequently encountered than functional PNET.

Entities:  

Mesh:

Year:  2011        PMID: 21964743     DOI: 10.1007/s10620-011-1912-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Utility of endoscopic ultrasonography with color Doppler function for the diagnosis of islet cell tumor.

Authors:  N Ueno; T Tomiyama; S Tano; S Wada; T Aizawa; K Kimura
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

Review 2.  Update on pancreatic endocrine tumors.

Authors:  Wendy L Frankel
Journal:  Arch Pathol Lab Med       Date:  2006-07       Impact factor: 5.534

Review 3.  Pancreatic endocrine tumors.

Authors:  Kjell Oberg
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

4.  Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas.

Authors:  Lyndon V Hernandez; Girish Mishra; Christopher Forsmark; Peter V Draganov; John M Petersen; Steven N Hochwald; Stephen B Vogel; Manoop S Bhutani
Journal:  Pancreas       Date:  2002-10       Impact factor: 3.327

5.  Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.

Authors:  Yoshihito Nakayama; Ryuichi Wada; Nobuhisa Yajima; Ken-ichi Hakamada; Soroku Yagihashi
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

6.  EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery.

Authors:  José Celso Ardengh; Gustavo Andrade de Paulo; Angelo Paulo Ferrari
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

7.  Usefulness of EUS-guided fine needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors.

Authors:  Angels Ginès; Enrique Vazquez-Sequeiros; María Teresa Soria; Jonathan E Clain; Maurits J Wiersema
Journal:  Gastrointest Endosc       Date:  2002-08       Impact factor: 9.427

8.  Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.

Authors:  Lucio Gullo; Marina Migliori; Massimo Falconi; Paolo Pederzoli; Rossella Bettini; Riccardo Casadei; Gianfranco Delle Fave; Vito D Corleto; Claudio Ceccarelli; Donatella Santini; Paola Tomassetti
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

Review 9.  Pancreatic neuroendocrine tumours.

Authors:  H L O'Grady; K C Conlon
Journal:  Eur J Surg Oncol       Date:  2007-10-29       Impact factor: 4.424

10.  Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis.

Authors:  Eva-Maria Duerr; Yusuke Mizukami; Aylwin Ng; Ramnik J Xavier; Hirotoshi Kikuchi; Vikram Deshpande; Andrew L Warshaw; Jonathan Glickman; Matthew H Kulke; Daniel C Chung
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

View more
  25 in total

1.  Pancreatic Cyst Fluid Vascular Endothelial Growth Factor A and Carcinoembryonic Antigen: A Highly Accurate Test for the Diagnosis of Serous Cystic Neoplasm.

Authors:  Rosalie A Carr; Michele T Yip-Schneider; Scott Dolejs; Bradley A Hancock; Huangbing Wu; Milan Radovich; C Max Schmidt
Journal:  J Am Coll Surg       Date:  2017-05-18       Impact factor: 6.113

2.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 3.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

Review 4.  State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors.

Authors:  Eric P Tamm; Priya Bhosale; Jeffrey H Lee; Eric M Rohren
Journal:  Surg Oncol Clin N Am       Date:  2016-04       Impact factor: 3.495

5.  Pancreatic Neuroendocrine Tumors: an Update.

Authors:  Alessandro Paniccia; Barish H Edil; Richard D Schulick
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

6.  Neuroendocrine neoplasm of pancreas with cystic degeneration mimicking mucinous cystic neoplasm.

Authors:  Uayporn Kaosombatwattana; Yoshiki Hirooka; Hiroki Kawashima; Eizaburo Ohno; Takuya Ishikawa; Hiroki Suhara; Hidemi Goto
Journal:  Clin J Gastroenterol       Date:  2018-03-13

7.  Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.

Authors:  Peter Herbert Kann; Roland Moll; Detlef Bartsch; Andreas Pfützner; Thomas Forst; Gianluca Tamagno; Joachim N Goebel; Verena Fourkiotis; Simona Raluca Bergmann; Maike Collienne
Journal:  Endocrine       Date:  2016-11-30       Impact factor: 3.633

Review 8.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

Review 9.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11

Review 10.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.